Aeluma's stock already prices in much of a successful FY28-FY29 commercialization, while commercial revenue is minimal and no volume customers are publicly named. Its III-V-on-silicon technology is real, but of $2.657M in revenue for the six months to December 2025, only $41k came from non-government work, and Q2 revenue fell year over year. Most of its 20+ customer engagements are still in evaluation or prototyping, and government contracts de-risk the physics, not adoption. x.com 

Aeluma is a risky investment because its roughly $300M market cap rests on about $5M of revenue from government R&D, with zero commercial customers. Its III-V-on-silicon technology is real, but the open question is who buys outside government. The near-50% surge on $4M of US government contracts, with Tower Semiconductor and Sumitomo Chemical handling wafers, looks like an overreaction to a contract that is not large; the stock trades at about 58x sales alongside a $50M ATM and insider selling. … Show more

Aeluma's post-earnings drop looks like a reaction to headline numbers, while the call's tone suggests more customers are qualifying its technology. That makes the $26-27 area attractive for long-run believers, with support at the 10-day EMA and prior $25.94 high and a path to $35.65 if it holds. It remains an extremely high-risk bet: a market cap in the hundreds of millions against minuscule revenue, resting on a customer win. @NickNemo17's critical research makes valid points. x.com  x.com  x.com 

Aeluma's quantum dot technology is years too early, so investing now mostly funds dilution for R&D. A Goldman Sachs note sees MicroLED far from any co-packaged optics volume ramp and does not even mention quantum dots. Even with product ready in Q4 2026, sampling and qualification could push volume to 2029, and Aeluma may end up like POET in 2025 with constant share sales. In a correction, only revenue backs valuations; Sivers and Applied Optoelectronics ramp CW laser volume within months. x.com  … Show more

Aeluma's technology is ready but meaningful revenue is still far off, so it is a wait-and-see stock until a signed purchase order arrives. Q3 revenue of $1.2M missed the $1.35M consensus and FY2026 guidance narrowed to $4.2-4.6M, blamed on government contract delays. It grows quantum-dot lasers on 200mm silicon with MOCVD and has moved production to Tower Semiconductor, but H2 2026 is for sampling and yields; problems in the first qualification could add long delays. x.com  x.com 

Aeluma is a speculative small cap with a rare ability to put compound semiconductors on standard 200mm and 300mm silicon, making quantum dot lasers, nonlinear photonics and detectors that feed CPO, VCSELs and quantum photonic ICs. A seed investor is Shuji Nakamura, the Nobel laureate who co-invented the blue LED. Catalysts include $4M+ in government contracts, Tower Semi and Sumitomo partnerships, and DARPA, NASA and Navy customers. Risks are a $50M ATM, heavy insider selling and no revenue yet. … Show more

Aeluma is in almost the same setup as Lightwave Logic before its big run, after winning over $4M in US government contracts for quantum dot lasers and quantum nonlinear materials with Tower Semiconductor as manufacturing partner. Lightwave Logic, small and pre-revenue with Tower and government validation, rose 138% in a month. Aeluma's lasers target AI data center links as speeds push toward 3.2T. It is even earlier stage, so upside is larger if the technology converts, but risk is high. x.com